Literature DB >> 6836328

Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.

M Slavik, J H Saiers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6836328

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  The role of acetylcysteine in clinical toxicology.

Authors:  R J Flanagan
Journal:  Med Toxicol       Date:  1987 Mar-Apr

2.  Ifosfamide chemotherapy for pancreatic carcinoma.

Authors:  L H Einhorn; P J Loehrer
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity.

Authors:  R L Gamelli; W B Ershler; M P Hacker; R S Foster
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.

Authors:  J C Roberts; D J Francetic; R T Zera
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.

Authors:  N C Munshi; P J Loehrer; S D Williams; C Langefeld; G Sledge; C R Nichols; B J Roth; A Neuman; W B Walsh; L H Einhorn
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

6.  Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols.

Authors:  N Brock; P Hilgard; J Pohl; K Ormstad; S Orrenius
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 7.  Ifosfamide clinical pharmacokinetics.

Authors:  T Wagner
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

Review 8.  Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity.

Authors:  Kanchanlata Singh; Mustansir Bhori; Yasar Arfat Kasu; Ganapathi Bhat; Thankamani Marar
Journal:  Saudi Pharm J       Date:  2017-12-19       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.